The Office of International Des Epizooties (OIE) classifies all 3 diseases as reportable List B conditions, and many OIE member nations maintain regulatory animal health controls to prevent the occurrence or spread of these diseases. 3 These controls often include a requirement that equids presented for importation be seronegative for each of the 4 infectious agents involved. Many nations, including the United States, have maintained piroplasmosis-, dourine-, and glanders-free equine populations for many years. 1, 3, 6 Four separate complement fixation tests (CFT) are usually conducted for serodiagnostic purposes, 1 CFT for antibodies against each of the infectious agents. 2, 3 The OIE also prescribes alternative test methods, and these must be used with sera that produce anticomplementary or otherwise spurious reactions in the CFT. [3] [4] [5] 9 This testing is laborious and complex because no single accepted method can be applied to conduct the entire battery of alternative tests. Indirect fluorescent antibody (IFA) tests can be used to detect B. equi and B. caballi antibodies, an enzyme-linked immunosorbent assay (ELISA) can be used to detect B. mallei antibody, and IFA, ELISA, or agar gel im-From the Diagnostic Bacteriology Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and Plant Health Inspection Service, US Department of Agriculture, Ames, IA 50010.
Received for publication May 26, 1998. munodiffusion (AGID) tests are approved for T. equiperdum serodiagnosis. [3] [4] [5] 9 Sera that contain antibodies to 1 or more of these pathogens produce reproducible, unique immunoblot patterns against homologous agent antigens. This observation has been used to develop an immunoblot method permitting the rapid simultaneous performance of serodiagnostic tests for all 4 pathogens on a single nitrocellulose strip. The 4 antigens used in the immunoblot method were identical to those used in the CFT and were prepared as previously detailed. 2, 3 Each antigen was diluted 1:20 (v/v) in water and then boiled 5 minutes in an equal volume of denaturing solution. 7 Diluted denatured antigens were then applied in repeating series to individual 3-mm-wide lanes of 8-16% (v/v) polyacrylamide gradient gels a (Fig. 1 ). Subsequent gel electrophoresis and semidry transfer of separated antigens onto nitrocellulose membranes b was completed in a standard manner. 7 Membranes were then frozen (Ϫ70 C) and retrieved as needed with no detectable degredation in quality for at least 6 months when thus stored.
Test sera were 1 each for B. mallei, B. caballi, B . equi, and T. equiperdum. Because the final positive serum control dilution was 1:20 (v/v), each agent-specific serum sample was thus present at 1:80 (v/v) ( Fig. 1) . Following serum incubation, all strips were washed in TBST 4 times within a 20-minute period and then incubated 30 minutes with a 1:350 (v/v) dilution of goat-origin anti-equine IgG and IgM alkaline phosphate conjugate. Diluent was TBST to which 2.5% (v/ v) fish gelatin and 1% (v/v) normal goat serum had been added. Strips were then washed as described previously and incubated with 5-bromo-4-chloro-3-indolyl-phosphate, nitroblue tetrazolium substrate. e Color development was terminated when all 4 antigenic lanes on the positive control blot were clearly delineated with their characteristic patterns.
The immunoblot test and the CFT were both applied to 2-fold serial dilutions of 19 reference positive control equine piroplasmosis, dourine, and glanders antisera maintained at the National Veterinary Services Laboratories, Ames, Iowa, and to sera from horses, ponies, and donkeys never exposed to any of the 4 pathogens involved. An additional 33 anticomplementary sera not usable for the CFT were evaluated both by immunoblot and by the alternative agent-specific methods. One hundred forty-eight field-origin sera from foreign sources had previously been determined CFT positive for piroplasmosis, dourine, or glanders, and these sera also were tested by immunoblot at the 1:20 (v/v) dilution as well.
Each component of the quadrivalent positive control serum reveals the homologous antigenic lane without interfering with the specific patterns expected in the other 3 lanes (Fig. 1) . Each of these 4 patterns is specific and characteristic for each of the pathogens involved (Fig. 2) . Sera from uninfected equids do not react specifically with any of the 4 antigen lanes, and sera containing antibodies against only 1 pathogen react characteristically only with the lane containing the appropriate homologous antigen. End point serial dilution comparisons of the CFT and the immunoblot demonstrated that blotting was 2-4-fold more sensitive for piroplasmosis and glanders antibody detection and of equal sensitivity for dourine antibody detection. Those differences, however, were not significant (P Ͼ 0.05). 8 All 33 CFT-incompatable sera were successfully tested by both immunoblot and by the alternative methods mentioned previously. All were seronegative for the diseases involved. Field-origin sera that were CFT positive for B. caballi antibodies (n ϭ 45) or B. equi antibodies (n ϭ 44) were tested by immunoblot and were positive by that method also. An additional 13 sera were CFT positive for antibodies to both Babesia species; 11 were bivalently blot positive, and the other 2 were blot positive for B. equi (1 serum) or B. caballi (1 serum). The discrepant CFT titers were low positive and not verifiable by IFA tests. Of the 5 field-origin glanders CFTpositive sera available, 3 were both immunoblot and ELISA seropositive; the other 2 were seronegative by both methods. Field-origin dourine CFT-positive sera (n ϭ 39) were evaluated by immunoblot, and 28 were positive. Two of the 11 discrepant sera were incorrectly interpreted as seronegative by immunoblot. The other 9 discrepant sera were from dourine-free horses originating from nations regarded as dourine free. Most equine sera, including those from normal horses, contained antibodies binding to a 60-kD component of the dourine CFT and immunoblot antigen (Fig. 2, panel C) . For the 9 apparent dourine CFT false-positive sera, equine antibody may have bound to this nonspecifically cross-reactive antigen sufficiently such that complement was consumed and false-positive CFT responses occurred. Use of the immunoblot in these cases was helpful in demonstrating that dourine-specific antigen-antibody binding did not occur.
For the foreseeable future, CFT will remain the most generally accepted, internationally approved procedure for equine piroplasmosis, glanders, and dourine serodiagnosis. 2, 3 For sera not capable of being tested by CFT, immunoblotting offers a unitary alternative method. As additional field-origin sera are acquired from equids in disease-endemic areas, comparative CFT, IFA tests, AGID tests, ELISA, and immunoblot analysis may support the use of immunoblotting as a rapid, convenient single confirmatory test method for piroplasmosis, dourine, and glanders serodiagnosis.
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